On the basis of prior research suggesting that PTSD is associated with risk for dementia, accelerated DNAm age, and other indices of advanced cellular aging [15–17], we hypothesized that aging patients with PTSD would show elevated levels of some or all of the brain age- and dementia-associated plasma biomarkers Aβ40, Aβ42, GFAP, NfL, and pTau181. This evidence concerns the gene GFAP and post-traumatic stress disorder.